세계의 요로결석 관리 기기 시장 : 디바이스 유형, 치료 유형, 디바이스 재료, 용도, 최종사용자별 - 예측(2025-2030년)

The Urolithiasis Management Devices Market was valued at USD 490.76 million in 2024 and is projected to grow to USD 527.03 million in 2025, with a CAGR of 7.73%, reaching USD 767.30 million by 2030.

The current landscape of urolithiasis management devices is witnessing an era of rapid innovation and transformative change. In today's healthcare environment, technological advances have led to the development of devices that offer enhanced precision, efficiency, and safety for the treatment of kidney stones, ureteral stones, and bladder stones. This dynamic field blends intricate medical engineering with evolving clinical practices to address one of the most prevalent urinary tract disorders.

Stakeholders including clinicians, biomedical engineers, and hospital administrators are consistently on the lookout for solutions that not only improve patient outcomes but also reduce procedural complications. The integration of advanced imaging, minimally invasive intervention techniques, and improved device ergonomics has dramatically reshaped practices in stone management. This evolution signifies a progressive shift where traditional methods are being supplemented or even replaced by state-of-the-art devices designed to manage urolithiasis through both endoscopic and non-invasive approaches.

In this environment, expert insights and evidence-based data guide decision-making and foster investments in research and development. As innovation continues to disrupt conventional methods, the interplay between clinical efficacy and technological advancements defines the roadmap for future strategies. The opportunity to leverage these improvements for enhanced clinical workflows and patient care is more pronounced than ever, indicating a promising outlook for the market overall.

Transformative Shifts Driving the Urolithiasis Market

Recent years have been marked by transformative shifts that are redefining the urolithiasis management device market. The pace of technological innovation has ushered in devices that are not only more efficient but also safer and easier to use. Innovations have led to improvements in imaging techniques, enhanced navigation capabilities, and real-time feedback mechanisms during surgeries. This evolution has partly been driven by a growing demand for minimally invasive procedures, improved patient comfort, and reduced recovery times.

Regulatory policies have also evolved, facilitating faster market entry for innovative medical devices while ensuring patient safety remains paramount. Collaborative efforts between clinical practitioners and technical experts have fostered the creation of devices that are increasingly tailored to the nuances of urolithiasis treatment. Healthcare providers are now more inclined to adopt technology that integrates seamlessly with existing hospital infrastructure and simplifies complex procedures through automation and digital oversight.

Furthermore, the market is witnessing a gradual shift from traditional surgical methods to digitally-enhanced techniques that incorporate AI-driven diagnostics and procedural guidance. Investment in research and development continues to flow steadily as industries recognize the untapped potential of these novel devices. The transformation in the landscape is underpinned by an evolving ecosystem that blends innovation with practical, evidence-based clinical outcomes. As clinicians and medical device manufacturers work synergistically, the promise of improved therapeutic outcomes combined with cost-efficiency is rapidly becoming a reality.

Deep Dive: Market Segmentation Insights into Device, Treatment, Material, Application, and End Users

A comprehensive analysis of the urolithiasis management device market reveals an intricate segmentation strategy that captures the diversity of the market landscape. The segmentation based on device type dissects the market into segments that include guidewires, lithotripters, stents, and ureteroscopes, each playing a unique role in the treatment protocol. When the market is examined through the lens of treatment type, it is clear that extracorporeal shock wave lithotripsy, intracorporeal lithotripsy, and percutaneous nephrolithotomy are at the forefront of procedural choices, each offering distinct advantages regarding invasiveness and recovery time.

The analysis is further enriched by segmentation based on device material, categorizing the market into metal-based devices and polymer-based devices. This classification helps in understanding performance differences, durability, and patient-specific considerations that underline treatment efficacy. Moreover, by looking at the application-based categorization, the market study addresses conditions pertaining to bladder stones, kidney stones, and ureteral stones, thereby offering a tailored view of therapeutic needs and operational specialties.

Another dimension of market segmentation focuses on the end user, encompassing ambulatory surgical centers, hospitals, and specialty clinics. This perspective of the segmentation strategy allows for a better understanding of market demand, acquisition trends, and the unique requirements of each end user category. The interplay of these diverse segments contributes to a holistic view of current market dynamics, ensuring that every aspect from technological innovation to clinical application is captured in the overall assessment. This nuanced framework is essential for stakeholders looking to strategize in a competitive and rapidly evolving landscape.

Based on Device Type, market is studied across Guidewires, Lithotripters, Stents, and Ureteroscopes.

Based on Treatment Type, market is studied across Extracorporeal Shock Wave Lithotripsy, Intracorporeal Lithotripsy, and Percutaneous Nephrolithotomy.

Based on Device Material, market is studied across Metal-Based Devices and Polymer-Based Devices.

Based on Application, market is studied across Bladder Stones, Kidney Stones, and Ureteral Stones.

Based on End User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.

Regional Dynamics Shaping Global and Local Markets

The global distribution of urolithiasis management devices is significantly influenced by varying regional characteristics and healthcare infrastructure maturity. In the Americas, market growth is primarily driven by well-established healthcare systems and an increasing adoption rate of minimally invasive procedures. Regulatory frameworks in the region encourage early adoption of innovative technologies, thereby setting the stage for sustained market growth.

Across Europe, the Middle East, and Africa, there is a noticeable trend towards gradual modernization of healthcare delivery systems. Advanced medical centers, combined with the growing emphasis on patient safety and device efficacy, have markedly contributed to regional market dynamics. Clinical adoption in these regions is enhanced by targeted initiatives aimed at improving patient outcomes and reducing post-procedural complications. The diversity of healthcare systems within these areas presents both challenges and opportunities, requiring tailored strategic responses from manufacturers and service providers.

Meanwhile, the Asia-Pacific region is emerging as one of the fastest-growing markets for urolithiasis management devices. Rising healthcare expenditures, expanding infrastructure, and a surge in medical tourism are key factors driving market evolution. The blend of traditional practices with modern medical innovation creates a fertile ground for advanced device adoption. Furthermore, this region has seen significant improvements in access to specialized healthcare services, facilitating the integration of new technological advancements into current clinical practices. Together, these regional insights underscore a global scenario where local demand, regulatory policies, and infrastructure readiness collectively shape market trajectories.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Innovators in the Urolithiasis Device Sphere

The competitive landscape in the urolithiasis management device market is characterized by contributions from several leading innovators who have significantly influenced both technological advancement and market penetration. Industry pioneers such as Advanced MedTech Holdings have consistently set benchmarks through extensive research and development initiatives. Similarly, companies like AKSM, Ltd. and Avvio Medical, Inc. are making remarkable strides in designing devices that cater to highly specialized clinical requirements, while Becton, Dickinson and Company alongside Boston Scientific Corporation are leveraging their global footprint to drive widespread acceptance of novel treatment methodologies.

Other key players including Calyxo Inc. and Coloplast A/S have focused on enhancing device ergonomics and integrating user-centric functionalities to ensure seamless operation during surgical procedures. Cook Group Incorporated and DirexGroup bring a strategic blend of technological innovation and robust distribution networks that position them as reliable partners in the market. Additionally, Dornier MedTech GmbH, Dyne Medical Group Inc., and E.M.S. Electro Medical Systems S.A. have been pivotal in pushing the boundaries of device precision and patient safety.

EDAP TMS SA, Elmed Lithotripsy Systems, EndoTheia, Inc., and Karl Storz GmbH & Co. KG are also at the forefront of transformative developments in this sector. The contributions from innovators such as Nissha Medical Technologies, Olympus Corporation, Quanta System S.p.A., Richard Wolf GmbH, Siemens Healthineers, SonoMotion, and Teleflex Incorporated illustrate the market's evolving nature. Each of these companies has embraced a forward-thinking approach that not only enhances device functionality but also aligns with the latest trends in patient-centered care. Their collective efforts have led to significant improvements in device reliability, user experience, and clinical outcomes, positioning the industry for long-term growth.

The report delves into recent significant developments in the Urolithiasis Management Devices Market, highlighting leading vendors and their innovative profiles. These include Advanced MedTech Holdings, AKSM, Ltd., Avvio Medical, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Calyxo Inc., Coloplast A/S, Cook Group Incorporated, DirexGroup, Dornier MedTech GmbH, Dyne Medical Group Inc., E.M.S. Electro Medical Systems S.A., EDAP TMS SA, Elmed Lithotripsy Systems, EndoTheia, Inc., Karl Storz GmbH & Co. KG, Nissha Medical Technologies, Olympus Corporation, Quanta System S.p.A., Richard Wolf GmbH, Siemens Healthineers, SonoMotion, and Teleflex Incorporated. Guiding Strategic Recommendations for Market Excellence

Industry stakeholders need to adopt a multi-faceted strategy to maintain a competitive edge in the evolving market of urolithiasis management devices. One of the first actionable recommendations is to ensure ongoing investment in research and development, particularly in areas that enhance device precision and improve patient safety. Stakeholders should collaborate closely with clinical research bodies to ensure that new products not only meet regulatory standards but also align with the evolving needs of the healthcare market.

Another key recommendation is to strengthen partnerships across the value chain, ranging from raw material suppliers to healthcare practitioners who deploy these devices in clinical settings. Effective collaboration can facilitate the integration of digital technologies and analytics, allowing companies to streamline operations and develop devices that deliver both cost efficiency and enhanced procedural outcomes. It is also advisable for manufacturers to remain agile in response to regional variations in market dynamics; tailoring strategies for different geographies by understanding local regulatory environments, healthcare priorities, and patient demographics can yield significant competitive advantages.

Moreover, companies should focus on training and support programs that empower clinical teams to fully leverage the benefits of advanced urolithiasis management technology. Emphasizing continuous education, workshops, and real-world case demonstrations can boost confidence among users and accelerate the adoption curve. Strategic investments in digital marketing and thought leadership are also critical in establishing a strong brand presence and influencing decision-makers in the healthcare sector. By adopting these recommendations, industry leaders can not only secure their market position but also drive transformative changes that resonate across clinical practices worldwide.

Concluding Reflections on Market Trends and Future Prospects

In conclusion, the current market for urolithiasis management devices is set on a promising path, driven by significant technological advancements and an increasing emphasis on minimally invasive procedures. The strategic integration of innovations, ranging from advanced imaging to digital analytics, has fundamentally altered the approach to managing urolithiasis. As stakeholders navigate this dynamic environment, a deep understanding of market segmentation, regional dynamics, and competitive forces remains critical.

The insights gathered from both qualitative and quantitative analyses suggest that market players must continue to invest in product development and embrace collaborative partnerships to meet the rising expectations of healthcare providers. The future of urolithiasis management is not solely reliant on isolated technological innovations but also on the seamless integration of these advancements within existing clinical infrastructures. As global healthcare demands evolve, businesses that maintain a patient-centric approach, focus on reliability, and adapt swiftly to market changes are likely to thrive.

The continuous evolution in this industry will undoubtedly usher in further developments that may set new standards for efficiency and efficacy in patient care. As medical professionals, researchers, and device manufacturers build on the current momentum, the overall impact on patient outcomes could be transformative. Ultimately, the convergence of innovation, strategic investments, and a comprehensive understanding of market dynamics will drive the future success and sustainability of the urolithiasis management device sector.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidence of urinary stones and increasing elderly population
    • 5.1.1.2. Rising proclivity for non-invasive surgeries and awareness of minimally invasive techniques
    • 5.1.1.3. Increasing adoption of innovative technologies in the hospital sector
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability and high cost of urolithiasis devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of portable and user-friendly urolithiasis management devices
    • 5.1.3.2. Technological advancements in minimally invasive devices for effective urolithiasis treatment
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns over probable side effects of the treatment
• 5.2. Market Segmentation Analysis
  • 5.2.1. Device Type: Rising preference for ureteroscopes owing to visual and mechanical excellence in stone extraction
  • 5.2.2. Application: Expanding application of urolithiasis management devices for bladder stone management
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Urolithiasis Management Devices Market, by Device Type

• 6.1. Introduction
• 6.2. Guidewires
• 6.3. Lithotripters
• 6.4. Stents
• 6.5. Ureteroscopes

7. Urolithiasis Management Devices Market, by Treatment Type

• 7.1. Introduction
• 7.2. Extracorporeal Shock Wave Lithotripsy
• 7.3. Intracorporeal Lithotripsy
• 7.4. Percutaneous Nephrolithotomy

8. Urolithiasis Management Devices Market, by Device Material

• 8.1. Introduction
• 8.2. Metal-Based Devices
• 8.3. Polymer-Based Devices

9. Urolithiasis Management Devices Market, by Application

• 9.1. Introduction
• 9.2. Bladder Stones
• 9.3. Kidney Stones
• 9.4. Ureteral Stones

10. Urolithiasis Management Devices Market, by End User

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Hospitals
• 10.4. Specialty Clinics

11. Americas Urolithiasis Management Devices Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Urolithiasis Management Devices Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Urolithiasis Management Devices Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2024
• 14.2. FPNV Positioning Matrix, 2024
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Nissha and Endotheia unveil FlexStone Basket, enhancing kidney stone removal through innovation and collaboration
  • 14.3.2. FDA de novo clearance granted to Stone Clear, a non-invasive device for managing post-lithotripsy kidney stones and reducing relapse risk
  • 14.3.3. Olympus enhances urolithiasis management with FDA-cleared RenaFlex single-use flexible ureteroscope
  • 14.3.4. Calyxo receives FDA approval for redesign of device that collects kidney stone fragments
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Advanced MedTech Holdings
• 2. AKSM, Ltd.
• 3. Avvio Medical, Inc.
• 4. Becton, Dickinson and Company
• 5. Boston Scientific Corporation
• 6. Calyxo Inc.
• 7. Coloplast A/S
• 8. Cook Group Incorporated
• 9. DirexGroup
• 10. Dornier MedTech GmbH
• 11. Dyne Medical Group Inc.
• 12. E.M.S. Electro Medical Systems S.A.
• 13. EDAP TMS SA
• 14. Elmed Lithotripsy Systems
• 15. EndoTheia, Inc.
• 16. Karl Storz GmbH & Co. KG
• 17. Nissha Medical Technologies
• 18. Olympus Corporation
• 19. Quanta System S.p.A.
• 20. Richard Wolf GmbH
• 21. Siemens Healthineers
• 22. SonoMotion
• 23. Teleflex Incorporated